ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,459.10
      1.11%
      US Tech 100
      18,522.40
      1.05%
      Dow Jones
      40,589.34
      1.64%
      Brent Oil
      79.745
      -2.20%
      Bitcoin
      67,909.51
      3.24%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. X4 Pharmaceuticals Inc (XFOR)

      7. X4 Pharmaceuticals Inc (XFOR) Financials

      X4 Pharmaceuticals Inc

      X4 Pharmaceuticals Inc (XFOR)

      NASDAQ
      0.862
      -0.0028
      (-0.32%)
      At close: July 26 4:00PM
      Delayed by 15 minutes
      0.86
      -0.002
      ( -0.23% )
      After Hours: 7:24PM
      Delayed by 15 minutes

      X4 Pharmaceuticals Inc Financial Summary

      The current XFOR market cap is 144.43M. The company's latest EPS is USD -0.6024 and P/E is -1.43.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -29.3M-25.81M-27.21M-25.2M-37.29M
      Net Income -24.02M-55.71M-2.31M-19.13M-51.77M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 03M000
      Operating Income -47.8M-59.87M-85.11M-88.08M-107.52M
      Net Income -53.4M-62.13M-102.64M-96.41M-101.17M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 124.41M173.4M173.29M147.26M112.18M
      Total Liabilities 72.73M105.86M105.7M96.16M111.15M
      Total Equity 51.68M67.54M67.59M51.1M1.04M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 160.7M122.87M117.18M155.59M147.26M
      Total Liabilities 31.48M50.07M52.76M81.54M96.16M
      Total Equity 129.22M72.8M64.41M74.05M51.1M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -26.51M-47.94M-68.77M-96.51M-33.6M
      Investing -9k-4.89M-10.05M-14.88M-5.32M
      Financing -2.12M67.21M88.42M88.52M N/A
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -48.06M-58.82M-70.91M-77.1M-96.51M
      Investing 27.23M-1.36M-615k-103k-14.88M
      Financing 140.66M12.39M74.25M117.23M88.52M

      Stats and Ratios

      Market Cap 144.43M
      Price to Earnings Ratio -1.43
      Price to Sales Ratio 0
      Price to Cash Ratio 1.46
      Price to Book Ratio 2.83
      Dividend Yield -

      Share Statistics

      Shares Outstanding 167.94M
      Average Volume (1 week) 1.45M
      Average Volume (1 Month) 2.3M
      52 Week Change -51.96%
      52 Week High 1.88
      52 Week Low 0.5311
      Spread (Intraday) 0.02 (2.27%)

      Company Info

      Company Name X4 Pharmaceuticals Inc
      Address 3411 silverside road tatnall
      wilmington, delaware 19810
      Website https://www.x4pharma.com
      Industry biological pds,ex diagnstics (2836)